The usefulness of p63 as a marker of breast myoepithelial cells

In Vivo

Volumn 17, Issue 6, 2003, Pages 573-576

  Batistatou, Anna ^a   Stefanou, Dimitrios ^a   Arkoumani, Evdokia ^a   Agnantis, Niki J ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Breast; Myoepithelial; p63

Indexed keywords

ACTIN; CALDESMON; CALPONIN; CELL MARKER; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN; CYTOKERATIN 14; CYTOKERATIN 17; CYTOKERATIN 5; CYTOKERATIN 7; MASPIN; MYOSIN HEAVY CHAIN; NUCLEAR PROTEIN; PROTEIN P63; PROTEIN S 100;

BIOPSY; BREAST CARCINOMA; BREAST CELL; BREAST LESION; CANCER INFILTRATION; CARCINOMA IN SITU; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FIBROBLAST; HUMAN; IMMUNOHISTOCHEMISTRY; MYOEPITHELIUM CELL; PATHOLOGY; PROTEIN LOCALIZATION; REVIEW; SENSITIVITY AND SPECIFICITY; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER; STAINING; STANDARD; STROMA; VASCULAR SMOOTH MUSCLE;

EID: 0842287714     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Deugnier MA, Teuliere J, Faraldo MM, Thierry JP and Glukova MA: The importance of being a myoepithelial cell. Breast Cancer Res 4: 224-230, 2002.
2. Petersen OW, Nielsen HL, Gudjonsson T, Villadesen R, Ronnov-Jessen L and Bissell MJ: The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion. Breast Cancer Res 3: 213-217, 2001.
3. Agnantis NJ and Ioannidou-Mouzaka L: Histopathological diagnosis of D.C.I.S. breast cancer. In: De Oliveira CF, Oliveira HM, eds. Proceedings of the 10th International Meeting of Gynaecological Oncology. Monduzzi Editore SpA, Bologna, Italy 335-338m 1997.
4. Yaniji H, Gown AM and Sneige N: Detection of stromal invasion in breast cancer: The myoepithelial markers. Adv Anat Pathol 7: 100-109, 2000.
5. Werling RW, Hwang H, Yaziji H and Gown AM: Immunohistochemical distinction of invasive from noninvasive breast lesions: A comparative study of p63 versus calponin smooth muscle myosin heavy chain. Am J Surg Pathol 27: 82-90, 2003.
6. Gusterson BA, Warburton MJ, Mitchell D, Ellison M, Neville AM and Rusland PS: Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res 42: 4763-4770, 1982.
7. Gould VE, Jao W and Battifora H: Ultrastructural analysis in the differential diagnosis of breast tumors: The significance of myoepithelial cells, basal lamina, intracytoplasmic lumina and secretory granules. Pathol Res Pract 167: 45-70, 1980.
8. Gottlieb C, Raju U and Greenwald KA: Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: An immunohistochemical study. Mod Pathol 37: 135-140, 1990.
9. Papotti M, Eusebi V, Gugliotta P and Bussolati G: Immunohistochemical analysis of benign and malignant papillary lesions of the breast. Am J Surg Pathol 7: 451-461, 1983.
10. Damiani S, Ludvikova M, Tomasic G, Bianchi S, Gown AM and Eusebi V: Myoepithelial cells and breast basal lamina in poorly differentiated in situ ductal carcinoma of the breast. Virchows Arch 197: 271-273, 2002.
11. Bussolati G: Actin-rich (myoepithelial) cells in lobular carcinoma in situ of the breast. Virchows Arch B Cell Pathol Mol Pathol 32: 165-176, 1980.
12. Bussolati G, Botto Mica FB, Eusebi V and Betts CM: Myoepithelial cells in lobular carcinoma in situ of the breast: A parallel immunocytochemical and ultrastructural study. Ultrastruct Pathol 2: 219-230, 1981.
13. Bussolati G, Alfani V, Weber K and Osborn M: Immunohistochemical detection of actin on fixed and embedded tissues: Its potential use in routine pathology. J Histochem Cytochem 28: 169-173, 1980.
14. Bussolati G, Papotti M, Foschini MP and Eusebi V: The interest of actin immunohistochemistry in diagnostic histopathology. Basic Appl Histochem 31: 165-176, 1987.
15. Gugliotta P, Sapino A, Macri L, Skaili O, Gabbiani G and Bussolati G: Specific demonstration of myoepithelial cells by anti-alpha smooth muscle actin antibody. J Histochem Cytochem 36: 659-663, 1988.
16. Lazard D, Sastrem X and Frid MG, Glukhova MA, Thiery JP and Koteliansky VE: Expression of smooth muscle-specofic proteins in myoepithelium and stromal fibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 90: 999-1003, 1993.
17. Foschini MP, Scarpellini F, Gown AM and Eusebi V: Differential expression of myoepithelial markers in salivary, sweat and mammary glands. Int J Surg Pathol 8: 29-37, 2000.
18. Dabbs DJ and Gown AM: Distribution of calponin and smooth muscle myosin heavy chain in fine-needle aspiration biopsies of the breast. Diagn Cytopathol 20: 203-207, 1999.
19. Wang NP, Wan BC, Skelly M, Frid MG, Glukhova MA, Koteliansky VE and Gown AM: Antibodies to novel myoepithelium associated proteins distinct between benign lesions and in-situ carcinoma from invasive carcinoma of the breast. Appl Immunohistochem 5: 141-152, 1997.
20. Joshi MG, Lee AK, Pedersen CA, Schnitt S, Camus MG and Hughs KS: The role of immunohistochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast. Mod Pathol 9: 57-62, 1996.
21. Heatley M, Maxwell P, Whiteside C and Toner P: Cytokeratin intermediate filament expression in benign and malignant breast disease. J Clin Pathol 48: 26-32, 1995.
22. Reis-Fihlo JS, Milanezi F and Schmitt FC: Maspin is expressed in the nuclei of breast myoepithelial cells. J Pathol 197: 271-273, 2002.
23. Lele SM, Graves K and Gatalica Z: Immunohistochemical detection of maspin is a useful adjunct in distinguishing radial sclerosing lesion from tubular varcinoma of the breast. Appl Immunohistochem Molecul Morphol 8: 32-36, 2000.
24. Gusterson BA, Monaghan P and Mahendran R: Identification of myoepithelial cells in human and rat breasts by anti-common acute lymphoblastic leukemia antigen antibody A12. J Natl Cancer Inst 77: 343-349, 1986.
25. Suzuko M, Ryoji K, Sugihara H, Bamba M, Kobayashi TK and Hattori T: Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Med Pathol 15: 397-405, 2002.
26. Reis-Filho JS and Schmitt FC: Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker. Adv Anat Pathol 9: 280-289, 2002.
27. Yang A, Kaghad M, Caput D and McKeon F: On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 18: 90-95, 2002.
28. Little NA and Jochemsen AG: p63. Int J Biochem Cell Biol 34: 6-9, 2002.
29. Dietz S, Rother K, Bamberger C, Schmale H, Mossnet J and Engeland K: Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73. Febs Letters 525: 93-99, 2002.
30. Flores ER, Tsai KY, Crowely D, Sengypta S, Yang A, McKeon F and Jacks T: p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416: 560-564, 2002.
31. Van Bokhoven H and McKeon F: Mutations on the p53 homolog p63: Allele-specific developmental syndromes in humans. Trends Mol Med 8: 133-139, 2002.
32. Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, Pohart A, Hoos A and Cordon-Cardo C: p63 expression profile in human normal and tumor tissues. Clin Cancer Res 18: 494-501, 2002.
33. Barbareschi M, Pecciarini L, Cangi MG, Macri E, Rizzo A, Viale G and Doglioni C: p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 25: 1054-1060, 2001.
34. Wang X, Mori I, Tang W, Nakamura M, Nakamura Y, Sato M, Sakuro N and Kakudo K: p63 expression in normal, hyperplastic and malignant breast tissues. Breast Cancer 9: 216-219, 2002.
35. Ribeiro-Silva A, Zambelli Ramahlo LN, Garcia SB and Zucoloto S: Is p63 reliable in detecting microinvasion in ductal carcinoma in situ of the breast? Pathol Oncol Res 9: 20-23, 2003.
36. Reis-Fihlo JS, Albergaria A, Milanezi F, Amendoeira I and Schmitt C: Naked nuclei revisited: p63 immunoexpression. Diagn Cytopathol 27: 135-138, 2002.
37. Reis-Fihlo JS, Milanezi F, Amendoeira I, Albergaria A and Schmitt C: p63 staining of myoepithelial cells in breast fine needle aspirates: A study of its role in differentiating in situ from invasive ductal carcinomas of the breast. J Clinic Pathol 55: 936-939, 2002.